Brandywine, MDNCT06463028Now EnrollingIRB Ready

Endometrial Cancer Clinical Trial in Brandywine, MD

Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Brandywine. Study-provided care at no cost to qualified participants.

Sponsored by Faeth Therapeutics

Quick Self-Assessment

See if you qualify for this Brandywine location

Preparing your pre-screening questions...

Expert Care in Brandywine

Access endometrial cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related endometrial cancer treatment provided free

Apply for This Brandywine Location

Check if you qualify for this endometrial cancer clinical trial in Brandywine, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Brandywine

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Brandywine site if eligible
  4. 4Begin participation

About This Endometrial Cancer Study in Brandywine

This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial cancer.

Sponsor: Faeth Therapeutics

Who Can Participate

Inclusion Criteria

Histologically confirmed diagnosis of endometrioid endometrial carcinoma.
Documented evidence of advanced or recurrent endometrial cancer that is not amenable to surgery/radiation for curative intent.
Participant has received at least 1 but not more than 4 prior systemic therapies. Prior therapy must include platinum-based chemotherapy and a checkpoint inhibitor, either separately or in combination. If a subject has been unable to be treated with checkpoint inhibitor in the past due to medical contraindications, consult with Medical Monitor.
PI3K/AKT/mTOR pathway gene alteration identified.
At least 1 measurable target lesion according to RECIST v1.1
Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 1 at Screening.
Non-pregnant, non-lactating females who are postmenopausal, surgically sterile or who agree to use effective contraceptive methods..

Exclusion Criteria

Participants with central nervous system metastases are not eligibl

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Brandywine?

Yes, this clinical trial (NCT06463028) has an active research site in Brandywine, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Endometrial Cancer Treatment Options in Brandywine, MD

If you're searching for endometrial cancer treatment options in Brandywine, MD, this clinical trial (NCT06463028) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Brandywine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all endometrial cancer clinical trials near you to find additional studies recruiting in your area.

More Endometrial Cancer Trials in Brandywine, MD

See all endometrial cancer clinical trials recruiting in Brandywine — not just this study.

Browse Endometrial Cancer Trials in Brandywine

Ready to Join in Brandywine?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Brandywine, MD